Skip to main content
Endocrinology logoLink to Endocrinology
. 2016 Feb;157(2):449–451. doi: 10.1210/en.2015-2060

A Bisphenol by Any Other Name…

Kimberly H Cox 1,
PMCID: PMC4733127  PMID: 26828808

Over the last 10 years, a large number of studies have examined the effects of exposure to endocrine-disrupting chemicals (EDCs). These range widely from epidemiological, toxicological, and ecological studies, to animal studies examining the effects of EDCs on development, reproduction, and metabolism (114). In 2009, The Endocrine Society published its first policy statement on EDCs, advocating for funding of EDC research, recommending research priorities, and working to increase public awareness about EDC exposure (15). This year, they released a second statement, in which the authors reviewed a carefully selected, up-to-date literature on developmental EDC exposure and made further recommendations for how the research community can continue to inform physicians and policymakers (16). So far, only 1 major change in policy has been made based on these and other recommendations, but there may be other changes to come (17). In 2012, the United States Food and Drug Administration concluded that there was enough scientific evidence to ban the use of 1 EDC, bisphenol A (BPA), in baby bottles and children's cups (18, 19). However, BPA is still found in thermal receipts, canned foods, and other products, and there are many other EDCs being used to produce consumer goods.

Recently, evidence has been mounting to support the ban of one of the substitutes for BPA used by manufacturers, bisphenol S (BPS) (2022). Like BPA, BPS is also detectible in human urine (23), is capable of activating estrogen and androgen receptor signaling pathways (24, 25), and has been shown to alter development, reproduction, and behavior (2527). In this edition of Endocrinology, Qiu et al (28) build on the existing BPS literature, performing a side-by-side comparison of the effects of BPA and BPS exposure during embryonic development on the zebrafish reproductive axis. They show that both BPA and BPS have dose-dependent effects on GnRH neuron number in the forebrains of zebrafish embryos, and increase kiss1, gnrh3, and esr1 gene expression. They then use pharmacological approaches to dissect the underlying mechanisms of BPA/BPS effects on gene expression. Interestingly, all 3 of the pathways examined: estrogen receptor signaling, thyroid hormone receptor activation, and aromatase activity, were necessary to observe the full effects of BPA/BPS on the changes in gene expression in the reproductive neuroendocrine axis.

A number of studies, using various model organisms, chemicals, and exposure paradigms, have previously shown that the kisspeptin system can be altered by EDC exposure (11, 2932). Similarly, thyroid hormone signaling (33, 34), estrogen receptor expression (11, 12), and the aromatase pathway (35) have also been altered by other EDCs. However, Qiu et al are the first to report on direct effects of low dose developmental exposure across multiple signaling pathways (28). Although their results are not completely straightforward, they do establish some principles that could be useful for the future study of these and other EDCs. Already, several consortiums are hard at work establishing protocols for the thorough study of EDC effects (3639). In addition, there are groups developing cell-based screens for chemicals (4043), which, in the future, may be used before chemicals being introduced onto the market. Data are accumulating in support of the notion that EDCs produce transgenerational epigenetic modifications (1012, 4447). This evidence obligates the scientific community to extend beyond traditional endpoints and pathways to more whole-system, unbiased approaches. This will rely upon teams of researchers working together using standardized processes in order to understand the full complement of mechanisms through which these chemicals are capable of acting. Although Qiu et al (28) are certainly not the first to point out that the “safer” alternatives to known EDCs may not be safer, it is important that the scientific community continues to build evidence to support skepticism about the chemicals we are exposed to on a daily basis.

Acknowledgments

This study was funded by National Institutes of Health grants P50 HD028138 and T32 HD007396.

Disclosure Summary: The author has nothing to disclose.

For article see page 636

Abbreviations:
BPA
bisphenol A
BPS
bisphenol S
EDC
endocrine-disrupting chemical.

References

  • 1. Meeker JD. Exposure to environmental endocrine disruptors and child development. Arch Pediatr Adolesc Med. 2012;166(10):952–958. [PubMed] [Google Scholar]
  • 2. Stokstad E. Ecology. Zombie endocrine disruptors may threaten aquatic life. Science. 2013;341(6153):1441. [DOI] [PubMed] [Google Scholar]
  • 3. Kloas W, Urbatzka R, Opitz R, et al. Endocrine disruption in aquatic vertebrates. Ann NY Acad Sci. 2009;1163:187–200. [DOI] [PubMed] [Google Scholar]
  • 4. Heindel JJ, Newbold R, Schug TT. Endocrine disruptors and obesity. Nat Rev Endocrinol. 2015;11(11):653–661. [DOI] [PubMed] [Google Scholar]
  • 5. Hatch EE, Nelson JW, Stahlhut RW, Webster TF. Association of endocrine disruptors and obesity: perspectives from epidemiological studies. Int J Androl. 2010;33(2):324–332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Schug TT, Blawas AM, Gray K, Heindel JJ, Lawler CP. Elucidating the links between endocrine disruptors and neurodevelopment. Endocrinology. 2015;156(6):1941–1951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. DiVall SA. The influence of endocrine disruptors on growth and development of children. Curr Opin Endocrinol Diabetes Obes. 2013;20(1):50–55. [DOI] [PubMed] [Google Scholar]
  • 8. Dickerson SM, Gore AC. Estrogenic environmental endocrine-disrupting chemical effects on reproductive neuroendocrine function and dysfunction across the life cycle. Rev Endocr Metab Disord. 2007;8(2):143–59. [DOI] [PubMed] [Google Scholar]
  • 9. Rebuli ME, Patisaul HB. Assessment of sex specific endocrine disrupting effects in the prenatal and pre-pubertal rodent brain [published online August 22, 2015]. J Steroid Biochem Mol Biol. doi: 10.1016/j.jsbmb.2015.08.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Rissman EF, Adli M. Minireview: transgenerational epigenetic inheritance: focus on endocrine disrupting compounds. Endocrinology. 2014;155(8):2770–2780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Gore AC, Walker DM, Zama AM, Armenti AE, Uzumcu M. Early life exposure to endocrine-disrupting chemicals causes lifelong molecular reprogramming of the hypothalamus and premature reproductive aging. Mol Endocrinol. 2011;25(12):2157–2168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Wolstenholme JT, Edwards M, Shetty SR, et al. Gestational exposure to bisphenol a produces transgenerational changes in behaviors and gene expression. Endocrinology. 2012;153(8):3828–3838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Rochester JR. Bisphenol A and human health: a review of the literature. Reprod Toxicol. 2013;42:132–155. [DOI] [PubMed] [Google Scholar]
  • 14. Vandenberg LN, Colborn T, Hayes TB, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev. 2012;33(3):378–455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30(4):293–342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Gore AC, Chappell VA, Fenton SE, et al. EDC-2: The Endocrine Society's second scientific statement on endocrine-disrupting chemicals. Endocr Rev. 2015;36(6):E1–E150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Vandenberg LN, Colborn T, Hayes TB, et al. Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. Reprod Toxicol. 2013;38:1–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. FDA. 21 CFR part 175: representative Edward J. Markey; filing of food additive petition. Federal Register. 2012;77(137):41953. [Google Scholar]
  • 19. FDA. 21 CFR part 177: indirect food additives: polymers. Federal Register. 2012;77(137):41899. [Google Scholar]
  • 20. Rosenmai AK, Dybdahl M, Pedersen M, et al. Are structural analogues to bisphenol a safe alternatives? Toxicol Sci. 2014;139(1):35–47. [DOI] [PubMed] [Google Scholar]
  • 21. Eladak S, Grisin T, Moison D, et al. A new chapter in the bisphenol A story: bisphenol S and bisphenol F are not safe alternatives to this compound. Fertil Steril. 2015;103(1):11–21. [DOI] [PubMed] [Google Scholar]
  • 22. Rochester JR, Bolden AL. Bisphenol S and F: a systematic review and comparison of the hormonal activity of bisphenol A substitutes. Environ Health Perspect. 2015;123(7):643–650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Liao C, Liu F, Alomirah H, et al. Bisphenol S in urine from the United States and seven Asian countries: occurrence and human exposures. Environ Sci Technol. 2012;46(12):6860–6866. [DOI] [PubMed] [Google Scholar]
  • 24. Viñas R, Watson CS. Bisphenol S disrupts estradiol-induced nongenomic signaling in a rat pituitary cell line: effects on cell functions. Environ Health Perspect. 2013;121(3):352–358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Kinch CD, Ibhazehiebo K, Jeong JH, Habibi HR, Kurrasch DM. Low-dose exposure to bisphenol A and replacement bisphenol S induces precocious hypothalamic neurogenesis in embryonic zebrafish. Proc Natl Acad Sci USA. 2015;112(5):1475–1480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Crump D, Chiu S, Williams KL. Bisphenol S alters embryonic viability, development, gallbladder size, and mRNA expression in chicken embryos exposed via egg injection [published online November 25, 2015]. Environ Toxicol Chem. doi: 10.1002/etc.3313. [DOI] [PubMed] [Google Scholar]
  • 27. Ji K, Hong S, Kho Y, Choi K. Effects of bisphenol s exposure on endocrine functions and reproduction of zebrafish. Environ Sci Technol. 2013;47(15):8793–8800. [DOI] [PubMed] [Google Scholar]
  • 28. Qiu W, Zhao Y, Yang M, Farajzadeh M, Pan C, Wayne NL. Actions of bisphenol A and bisphenol S on the reproductive neuroendocrine system during early development in zebrafish. Endocrinology. 2016;157:636–647. [DOI] [PubMed] [Google Scholar]
  • 29. Patisaul HB. Effects of environmental endocrine disruptors and phytoestrogens on the kisspeptin system. Adv Exp Med Biol. 2013;784:455–479. [DOI] [PubMed] [Google Scholar]
  • 30. Tena-Sempere M. Kisspeptin/GPR54 system as potential target for endocrine disruption of reproductive development and function. Int J Androl. 2010;33(2):360–368. [DOI] [PubMed] [Google Scholar]
  • 31. Bellingham M, Fowler PA, Amezaga MR, et al. Exposure to a complex cocktail of environmental endocrine-disrupting compounds disturbs the kisspeptin/GPR54 system in ovine hypothalamus and pituitary gland. Environ Health Perspect. 2009;117(10):1556–1562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Overgaard A, Holst K, Mandrup KR, et al. The effect of perinatal exposure to ethinyl oestradiol or a mixture of endocrine disrupting pesticides on kisspeptin neurons in the rat hypothalamus. Neurotoxicology. 2013;37:154–162. [DOI] [PubMed] [Google Scholar]
  • 33. Ishihara A, Nishiyama N, Sugiyama S, Yamauchi K. The effect of endocrine disrupting chemicals on thyroid hormone binding to Japanese quail transthyretin and thyroid hormone receptor. Gen Comp Endocrinol. 2003;134(1):36–43. [DOI] [PubMed] [Google Scholar]
  • 34. Jung KK, Kim SY, Kim TG, et al. Differential regulation of thyroid hormone receptor-mediated function by endocrine disruptors. Arch Pharm Res. 2007;30(5):616–623. [DOI] [PubMed] [Google Scholar]
  • 35. Yu L, Liu C, Chen Q, Zhou B. Endocrine disruption and reproduction impairment in zebrafish after long-term exposure to DE-71. Environ Toxicol Chem. 2014;33(6):1354–1362. [DOI] [PubMed] [Google Scholar]
  • 36. Schug TT, Abagyan R, Blumberg B, et al. Designing endocrine disruption out of the next generation of chemicals. Green Chem. 2013;15(1):181–198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Schug TT, Heindel JJ, Camacho L, et al. A new approach to synergize academic and guideline-compliant research: the CLARITY-BPA research program. Reprod Toxicol. 2013;40:35–40. [DOI] [PubMed] [Google Scholar]
  • 38. Heindel JJ, Newbold RR, Bucher JR, et al. NIEHS/FDA CLARITY-BPA research program update. Reprod Toxicol. 2015;58:33–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Schulte-Oehlmann U, Albanis T, Allera A, et al. COMPRENDO: focus and approach. Environ Health Perspect. 2006;114(suppl 1):98–100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Scholz S, Renner P, Belanger SE, et al. Alternatives to in vivo tests to detect endocrine disrupting chemicals (EDCs) in fish and amphibians–screening for estrogen, androgen and thyroid hormone disruption. Crit Rev Toxicol. 2013;43(1):45–72. [DOI] [PubMed] [Google Scholar]
  • 41. Rotroff DM, Dix DJ, Houck KA, et al. Using in vitro high throughput screening assays to identify potential endocrine-disrupting chemicals. Environ Health Perspect. 2013;121(1):7–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Grimaldi M, Boulahtouf A, Delfosse V, Thouennon E, Bourguet W, Balaguer P. Reporter cell lines for the characterization of the interactions between human nuclear receptors and endocrine disruptors. Front Endocrinol (Lausanne). 2015;6:62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Chen S, Hsieh JH, Huang R, et al. Cell-based high-throughput screening for aromatase inhibitors in the Tox21 10K library. Toxicol Sci. 2015;147(2):446–457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Xin F, Susiarjo M, Bartolomei MS. Multigenerational and transgenerational effects of endocrine disrupting chemicals: a role for altered epigenetic regulation? Semin Cell Dev Biol. 2015;43:66–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Walker DM, Gore AC. Transgenerational neuroendocrine disruption of reproduction. Nat Rev Endocrinol. 2011;7(4):197–207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Gillette R, Miller-Crews I, Nilsson EE, Skinner MK, Gore AC, Crews D. Sexually dimorphic effects of ancestral exposure to vinclozolin on stress reactivity in rats. Endocrinology. 2014;155(10):3853–3866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Stel J, Legler J. The role of epigenetics in the latent effects of early life exposure to obesogenic endocrine disrupting chemicals. Endocrinology. 2015;156(10):3466–3472. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Endocrinology are provided here courtesy of The Endocrine Society

RESOURCES